Related Experiment Video
Updated: Dec 21, 2025

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies
Published on: September 27, 2024
New Insights into Key Determinants for Adenosine 1 Receptor Antagonists Selectivity Using Supervised Molecular
Giovanni Bolcato1, Maicol Bissaro1, Giuseppe Deganutti2
1Molecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, via Marzolo 5, 35131 Padova, Italy.
Researchers studied adenosine receptors (ARs) and their ligands to understand drug development challenges. They investigated how selective antagonists bind to A1AR and A2AAR subtypes, focusing on water molecule roles.
Area of Science:
- Pharmacology and Drug Design
- Structural Biology
- Computational Chemistry
Background:
- Adenosine receptors (ARs), a class of G protein-coupled receptors (GPCRs), are crucial targets in drug discovery.
- Developing selective drugs for ARs is challenging due to complex ligand selectivity profiles.
- Recent advancements in determining the structure of the A1 adenosine receptor (A1AR) subtype offer new insights.
Purpose of the Study:
- To rationalize the selectivity profile of antagonists targeting A1AR and A2A adenosine receptors (A2AAR).
- To investigate ligand recognition trajectories and the influence of water molecules in the binding site.
- To provide structural insights for the development of more selective AR-targeting drugs.
Main Methods:
- Employed Supervised Molecular Dynamics (SMD) simulations to study ligand recognition pathways from an unbound state.
- Analyzed the binding site interactions, with a specific focus on the role of water molecules.
- Investigated two known selective antagonists for A1AR and A2AAR.
Main Results:
- Elucidated the recognition trajectories of selective A1AR and A2AAR antagonists.
- Identified the significant role of water molecules in mediating ligand binding and selectivity within the receptor subtypes.
- Provided a rational basis for understanding the observed selectivity profiles of the studied antagonists.
Conclusions:
- The study offers a deeper understanding of ligand selectivity mechanisms for adenosine receptor subtypes.
- Structural insights, particularly the role of water, can guide the design of novel, highly selective AR-modulating drugs.
- This work contributes to overcoming a key limitation in developing therapeutics targeting GPCRs like adenosine receptors.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
10:28A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
Published on: August 17, 2019
Related Concept Videos
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Dose-Response Relationship: Selectivity and Specificity